Pulmonary MRI—a new approach for the evaluation of febrile neutropenic patients with malignancies

By Rieger C.  

Supportive Care in Cancer, Vol. 16, Iss. 6, 2008-06 ,pp. : 599-606

Springer Publishing Company

Access to resources Recommend Favorite

Attitudes of patients to randomised clinical trials of cancer therapy

By Fallowfield L.J.   Jenkins V.   Brennan C.   Sawtell M.   Moynihan C.   Souhami R.L.  

European Journal of Cancer, Vol. 34, Iss. 10, 1998-09 ,pp. : 1554-1559

Elsevier

Access to resources Recommend Favorite

Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection

By Klastersky Jean   Paesmans Marianne  

Supportive Care in Cancer, Vol. 15, Iss. 2, 2007-02 ,pp. : 137-141

Springer Publishing Company

Access to resources Recommend Favorite

Ethical and Design Issues of Phase I Clinical Trials in Cancer Patients

By Grunwald Hans W.  

Cancer Investigation, Vol. 25, Iss. 2, 2007-03 ,pp. : 124-126

Informa Healthcare

Access to resources Recommend Favorite

Randomised Comparison of Ceftazidine and Imipenem as Initial Monotherapy for Febrile Episodes in Neutropenic Cancer Patients

By Aparicio J.   Oltra A.   Llorca C.   Montalar J.   Herranz C.   Gomez-Codina J.   Pastor M.   Munarriz B.  

European Journal of Cancer, Vol. 32, Iss. 10, 1996-09 ,pp. : 1739-1743

Elsevier

Access to resources Recommend Favorite